See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
SteelSky Ventures is a visionary AI technology venture fund focused on revolutionizing healthcare by backing groundbreaking companies that improve access, care, and outcomes in women's health. The firm invests across the spectrum of women's health — including consumer health, digital health, and healthcare infrastructure — taking a focused, thematic approach to the healthcare technology sector where AI-driven advancements are driving rapid growth. With $73 million in AUM, SteelSky carefully curates a powerful ecosystem of investment partners, industry experts, and corporate strategics (including LPs such as the American Hospital Association, Eli Lilly, and Blue Shield of California) to create an unparalleled advantage for portfolio companies, driving their growth and market leadership.
Notable quotes
“Women's health is an area of tremendous growth potential, and SteelSky is building a pipeline of the next billion-dollar healthcare giants.”
“For decades, women have shouldered the burden of fertility treatment. Posterity Health shifts the conversation ensuring that both partners are actively involved in the journey.”
“Women's health doesn't exist in a silo. By prioritizing male fertility, Posterity Health is redefining what comprehensive evidence-based reproductive care should be.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| myLaurel | Series B | — | 2025-11-06 |
| Posterity Health | Series A | $13m | 2025-02-19 |
| Midi Health | Series B | $60m | 2024-04-26 |
| Motivo Health | Series A | $14m | — |
| Bend Health | Series A | $32m | — |
| Commons Clinic | Series B | $26m | — |
| Twentyeight Health | Series A | — | — |
| Zipline | Growth | — | — |
| Cayaba Care | Seed | — | — |
| Lark Health | Series B+ | — | — |
Frequent co-investors
Fit check
Is SteelSky Ventures a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit